Financials

  • Market Capitalization 20.45 M
  • Employee 6
  • Founded 2009
  • CEO N/A
  • Website www.kalarx.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2MVT8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
4608
ATOS
Atossa Therapeutics, Inc. - Common Stock
2.37 USD+4.87%-2.87%+0.42%+160.44%20.41 M USD
4611
NXTC
NextCure, Inc. - Common Stock
6.10 USD-7.29%+250.57%+196.12%-53.44%22.03 M USD
4626
LGVN
Longeveron Inc. - Class A Common stock
0.64 USD+3.23%-3.03%-18.99%+12.03%19.93 M USD
4630
LPCN
Lipocine Inc. - Common Stock
2.38 USD+3.03%-5.56%+3.93%-17.93%19.62 M USD

新闻